Publisher
Springer International Publishing
Reference36 articles.
1. Autism and Developmental Disabilities Monitoring Network Principal Investigators. (2007). Prevalence of autism spectrum disorders – autism and developmental disabilities monitoring network, six sites, United States, 2000. MMWR Surveillance Summaries, 56, 1), 1–1),11. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/17287714.
2. Baio, J., Wiggins, L. D., Christensen, D. L., Maenner, M. J., Daniels, J., Warren, Z., … Dowling, N. F. (2018). Prevalence of autism Spectrum disorder among children aged 8 years — Autism and developmental disabilities monitoring network, 11 sites, United States, 2014. Morbidity and Mortality Weekly Report. Surveillance Summaries, 67(6), 1–23. https://doi.org/10.15585/mmwr.ss6706a1.
3. Bateman, B. T., Hernandez-Diaz, S., Rathmell, J. P., Seeger, J. D., Doherty, M., Fischer, M. A., & Huybrechts, K. F. (2014). Patterns of opioid utilization in pregnancy in a large cohort of commercial insurance beneficiaries in the United States. Anesthesiology, 120(5), 1216–1224. https://doi.org/10.1097/aln.0000000000000172.
4. Bourgeron, T. (2015). From the genetic architecture to synaptic plasticity in autism spectrum disorder. Nature Reviews Neuroscience, 16(9), 551–563. https://doi.org/10.1038/nrn3992. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/26289574.
5. Brogly, S. B., Turner, S., Lajkosz, K., Davies, G., Newman, A., Johnson, A., & Dow, K. (2017). Infants born to opioid-dependent women in Ontario, 2002–2014. Journal of Obstetrics and Gynaecology Canada, 39(3), 157–165. https://doi.org/10.1016/j.jogc.2016.11.009. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/28343557.